ABSTRACT: The overexpression and increased activity of the serine protease Kallikrein 5 (KLK5) is characteristic of inflammatory skin diseases such as Rosacea. The use of inhibitors of this enzyme -such as 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF·HCl) or the anti-human recombinant Kallikrein 5 (anti-KLK5) antibody -in the treatment of the disease has been limited due to their low bioavailability, for which their immobilization in drug delivery agents can contribute to making serine protease inhibitors clinically useful. In this work, we synthesized gold nanoparticles (GNP) coated with a mixture of hydroxyl-and carboxyl terminated thiolates (GNP.OH/COOH), whose carboxyl groups were used to further functionalize the nanoparticles with the serine protease inhibitor AEBSF·HCl either electrostatically or covalently (GNP.COOH AEBSF and GNP.AEBSF, respectively), or with the anti-KLK5 antibody (GNP.antiKLK5). The synthesized and functionalized GNP were highly water soluble, and they were extensively characterized using UV-VIS absorption spectroscopy, Transmission Electron Microscopy (TEM), Dynamic Light Scattering (DLS) and Thermogravimetric Analysis (TGA).
Introduction
Rosacea is a chronic, inflammatory skin disease characterized by erythema, telangiectasia and papulopustules.
1,2 Its etiology is not completely known yet and pharmaceutical products on the market commonly contain drugs that only act upon the medical symptoms. [3] [4] [5] As the first line of defense against pathogens, keratinocytes express the Toll-like receptor TLR-2 on their cell surface and in endosomal compartments, which can be activated by external agents. 6, 7 In Rosacea patients, the overexpression of TLR-2 enhances the sensitivity to external agents, increasing the expression and activity of the serine protease Kallikrein-5 (KLK5). 8, 9 In addition, the proteolytic activity of KLK5 is altered in this disease, producing pro-inflammatory cathelicidin peptides, which in turn leads to an increased IL-8 secretion. 1, [6] [7] [8] [9] An overall
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highly-water soluble. However, further functionalization with serine protease inhibitors yielded nanoparticles with low water solubility, making them unsuitable for biological applications, and which were no longer used in further experiments.
In order to obtain highly-water soluble particles, we considered using mixed coatings by including as well the thiolated PEG ligand with terminal hydroxyl groups (PEG.OH) as a water dispersing promoter. Thus, we synthesized nanoparticles GNP.OH/COOH, comprised of a gold core coated with a mixture of two different types of thiolated-PEG molecules: one with a hydroxyl terminal group (PEG.OH), which remains unreacted and provides water solubility, and a second one with a carboxyl terminal group (PEG.COOH), which can be further functionalized with serine protease inhibitors. Also, as control particles, hydroxyl-functionalized nanoparticles (GNP.OH)
were synthesized, comprised of a gold core coated with only one kind thiolated-PEG molecules (PEG.OH) with a terminal hydroxyl group. A schematic representation of these nanoparticles is shown in Figure 2 .
Both GNP.OH and GNP.OH/COOH also show an SPR band near λ= 515 nm as observed by UV-VIS absorption spectroscopy (See Supporting Information, Figure S 1 ). Both GNP.OH and GNP.OH/COOH also remain in solution after centrifugation for 30 min, for which they can be considered highly-water soluble as well. For this reason, centrifugation-dissolution cycles could not be used for purification of GNP.OH or GNP.OH/COOH. Instead, other methods were used, such as dialysis or filter tubes for centrifugation. GNP were preserved in a stable solution at room temperature for at least one year with no apparent sedimentation or aggregation.
As estimated by UV-VIS absorption spectroscopy, 22 the GNP have an average diameter ≤3 nm,
with an extinction coefficient of 1.49x10 6 In the case of GNP.antiKLK5, the resulting functionalized particles are of great importance as they could play three important roles at the same time in the treatment of Rosacea. The first role is the passive targeting, achieved by the nanometric size of the platform, permitting a much higher extravasation in inflamed tissues such as the skin in Rosacea patients, than in healthy skin. The S9 second role is the active targeting, which is provided by the antibody. 18, [23] [24] [25] As the anti-KLK5
antibody has a high affinity for KLK5 enzyme, their specific interaction could maximize the retention of the GNP at the tissues with higher concentration of KLK5, which is the case of the epidermis, especially in patients with Rosacea 1,9,26 . Finally, a third role is believed to be the therapeutic potential of the the antiKLK5 itself, as it could possibly have a KLK5 inhibitory activity.
Characterization of optimum GNP
UV-VIS absorption spectroscopy
All functionalized GNP (GNP.COOH AEBSF, GNP.AEBSF and GNP.antiKLK5) were characterized using UV-VIS absorption spectroscopy (See Supporting Information, Figure S 1 ).
They all show the characteristic SPR band at ca. λ= 520 nm as well as bands corresponding to the serine protease inhibitors they contain.). Results suggest a successful functionalization in all cases, with no evidence of aggregation.
Microscopy
The size, morphology and polydispersity of GNP were confirmed by Transmission Electron Microscopy (TEM) (Figure 4 ), in GNP.OH (A) and GNP.OH/COOH (B) samples. GNP.AEBSF (C), GNP.antiKLK5 (D) and GNP.COOH AEBSF (E) were also observed to prove that functionalization does not induce particle aggregation. For all samples observed, the size found for the majority of GNP was 1.5±0.7 nm, which also was the smallest size that could be detected due to the equipment resolution; the size distribution did not follow a typical Gaussian curve, but instead, they followed a right-tailed Fisher distribution ( Figure 5 ). Histograms show that the different GNP are monodispersed, as more than 40% of the counts have a diameter around 1.5 nm. However, the polydispersity of GNP.OH seems to be slightly higher than the rest, as the percentage of particles above 4 nm in diameter is 25%, while in the rest of the samples, the percentage above 4 nm is less than 15%. This higher polydispersity can readily be observed in the plot as the slope of the curve is lower for GNP.OH than for the rest of the particles. Size distribution plots from the different GNP shown as both total counts and relative count (%) can be seen in Supporting Information (Figure S 2) . 
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LDI-TOF mass spectrometry
The successful covalent functionalization was proven by Laser Desorption Ionization -Time of Flight Mass Spectrometry (LDI-TOF MS), by analyzing both GNP.COOH AEBSF and GNP.AEBSF in negative mode. For GNP.AEBSF, peaks observed at m/z 551 and 566, correspond to the AEBSF molecule covalently bonded through an amide linker to the polyethylene glycol spacer, fragments including six ethylene glycol units and either a two-or three-carbon chain respectively. These results show the effectiveness of the strategy for covalent functionalization. Figure S 9 ). The sample containing GNP.COOH AEBSF also shows a mass loss around 300 ºC, corresponding to the drug. In this case, the biggest mass loss observed around 100 ºC corresponds to high amounts of water, indicating the sample was not as dry as the rest of the particle samples. Therefore, the smaller mass loss at 300 ºC as compared to GNP.AEBSF does not mean a smaller proportion of drug in the sample, but only a higher water content. Thiolated-PEG molecules were not completely degraded at the temperatures reached (950 ºC), as seen by the lack of a mass stabilization of the sample, for which the total mass of them cannot be known.
Dynamic Light Scattering (DLS)
GNP.OH/COOH, GNP.COOH AEBSF, GNP.AEBSF and GNP.antiKLK5 nanoparticles were analyzed by DLS to assess their hydrodynamic diameters, their polydispersity, and whether S13 Based on the results of the different techniques concerning particle sizes, a schematic representation of the nanoparticles, the different functionalizations, and their sizes is shown in the Supporting Information (Figure S 10 ).
In vitro inhibition of KLK5
As a first step, in vitro enzymatic assays were performed to test whether the different kinds of nanoparticles functionalized with serine protease inhibitors can inhibit KLK5 activity.
Experiments were performed following the protocol described by the supplier. 27 For activity assays, KLK5 was incubated with a specific fluorogenic substrate in the absence or presence of the different functionalized nanoparticles (GNP.COOH AEBSF, GNP.AEBSF, GNP.antiKLK5), as well as with the free drug AEBSF·HCl or the anti-KLK5 antibody for comparison. GNP.OH and GNP.OH/COOH were used as controls. In Figure 6 , the percentage of inhibition calculated for each type of drug/particles was plotted against the concentration of S14 functional groups responsible for such inhibition ("active groups"). In GNP.OH/COOH, the term (Table S 2 ).
As expected, AEBSF·HCl in solution inhibits KLK5 activity, which could be attributed to the covalent attachment of the fluorosulphonyl group from the drug to the hydroxyl group of the serine
Concentration
Active groups (µM) a Enzymatic inhibition (%) Anti-KLK5 Ab (µg/mL) c S16 in the enzyme's active site, and thus being an irreversible inhibition. Interestingly, also control particles (GNP.OH and GNP.OH/COOH) display KLK5 inhibitory activity, suggesting a possible interaction between the GNP and the enzyme's active site, for example, the formation of hydrogen bonds or ionic bonds. These interactions might therefore affect the normal enzymatic activity.
GNP.OH showed a very different inhibitory behavior than the rest, following a Boltzmann
Sigmoidal model, and providing much less inhibition as compared by the IC50 values (P<0.001).
In contrast, GNP.OH/COOH and the rest of the particles or free drug, followed a One Phase
Exponential Association model, reaching inhibitions higher than 80%. No significant differences (P>0.05) were obtained between the inhibitory activity of the particles GNP.OH/COOH, GNP.AEBSF, GNP.COOH AEBSF, GNP.antiKLK5 or the free AEBSF.HCl; however, when the drug is ionically bonded in GNP.COOH AEBSF, a slight enhancement of the inhibition can be appreciated, which could be due to the non-covalent nature of the attachment, which permits some drug release, and therefore both the drug and the nanoparticles contribute to the overall inhibition. Statistical analysis can be seen in Supporting Information (Table S 4 ).
Finally, the free anti-KLK5 did not show inhibitory activity at similar concentrations as when it is in GNP.antiKLK5 (50 -1200 pg/mL). This can be explained as the molar concentration of KLK5 in the assay is almost one million times higher than the concentration of antibody. However, when the concentration of antibody is increased (1 -20 µg/mL), inhibition is achieved, which also follows an exponential behavior. These results show that the interaction between the anti-KLK5
antibody and the enzyme can actually inhibit the enzymatic activity, and which, to our knowledge, was not previously reported.
Internalization of GNPs in human keratinocytes
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To test the ability of gold nanoparticles to be internalized in human keratinocytes (HaCaT), GNP.OH/COOH nanoparticles were labelled with the fluorophore BODIPY by covalently bonding the fluorophore to the carboxylic acid groups forming an amide bond. Labelled particles were added to keratinocytes at a concentration of 30 µM of active groups. After 24 hours of incubation at 37ºC, internalization of nanoparticles was visualized by confocal fluorescence microscopy ( Figure 7) . As expected, no red signal was observed in non-treated control cells. In contrast, BODIPY-labelled nanoparticles were visualized in the cytoplasm of HaCaT cells incubated at 37ºC. Remarkably, the area of the nucleus is observed completely dark, showing that the particles do not enter the cell nucleus, for which they should not induce damage to DNA.
The cell internalization of drugs or proteins is hampered by their physicochemical properties; therefore, these particles could be used as an intracellular delivery system. For example, the potential use of anti-KLK5 antibody to block KLK5 in vivo, is hampered by the inability of antibodies to enter the target cells, as it is known that the cell membrane represents a nonpermissive barrier for the transport of antibodies across it. Therefore, as it is the case of GNP.antiKLK5, these nanoparticles could be used to drive cellular uptake of antibodies and target cytosolic KLK5 in HaCaT cells. 
Cytotoxicity assays
Although it is generally accepted that the toxicity of gold nanoparticles is low because of the low reactivity of the material, there is a growing interest in the study of their toxicity and life expentancy. It has been seen that the size of the gold nanoparticles influences the cytotoxicity, being the ones with a gold core diameter smaller than 2 nm the ones that present unusual reactivity in terms of oxidative stress; [28] [29] [30] however, toxicity is highly dependent on the outer functionalization of the GNP, and PEG entities relieve nanotoxicity and permit the GNP escaping the opsonization process in the immune response. 31 Hence, the cellular toxicity in human keratinocytes (HaCaT cells) was evaluated after incubation with the different nanoparticles by performing the MTT assay.
Control
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Cell viability of HaCaT keratinocytes was evaluated both in presence or absence of the glucan related zymosan, with the aim of setting up a cellular model that mimics Rosacea conditions, and since it is known that zymosan can activate the TLR-2 receptors, whose signalling pathway is involved in Rosacea-associated overexpression of KLK5 (see Figure 1) , 6, 7, 9 The results show that zymosan shows no cytotoxicity after 24 GNP.OH did not cause toxicity in keratinocytes since cell viability was close to 100% at all the concentrations tested (Figure 7 A) . These results were consistent with the reported alleviation of GNP toxicity by PEG functionalization. However, incubation with GNP.OH/COOH resulted in a significant decrease in cell viability, around 30% at concentrations above 5 µM (Figure 7 B) .
This effect could be attributed to the reactivity of free COOH groups on the surface of these S20 nanoparticles, prior to the functionalization with the desired drugs. Despite the toxicity levels observed with these particles, they should not represent a problem when the administration route is intended to be dermal, as the replication of keratinocytes in the skin occurs faster than the majority of cells in the organism, and the outer layer of the skin (stratum corneum) is entirely comprised of biologically dead cells.
In contrast, the serine protease inhibitor AEBSF·HCl was highly cytotoxic in solution, resulting in less than 10% of cell viability at 75 µM and undetectable cell viability levels at 100 µM, which completely impairs its potential therapeutic use. This high toxicity is most probably related to the reactivity of the fluorosulphonyl group, which might be interacting with other vital biomolecules of the cell. However, drug associated cytotoxicity was significantly reduced (p<0.05) when AEBSF is linked to the GNP through an electrostatic bond (GNP.COOH AEBSF), and especially through a covalent bond (GNP.AEBSF). (Figure 7 C) . The higher cytotoxicity observed for the electrostatically-bound AEBSF nanoparticles is therefore related to the expected dissociation of the drug at the cell culture conditions (aqueous solution, pH 7.4). These particles thus represent a great potential as a delivery system for highly cytotoxic drugs, as they could promote internalization while reducing drug-associated toxicity.
Incubation with GNP.antiKLK5 at concentrations up to 100 µM active groups (285 pg/mL antibody), modestly decreased cell viability to 80%. In contrast, incubation with the anti-KLK5
antibody did not cause any cytotoxic effect at equivalent antibody concentrations. (Figure 7 D) , and up to 1000 pg/mL of antibody (data not shown). This effect could be attributed to the presence of unreacted COOH groups on the GNP surface; however, the cell viability values are significantly higher with the attached antibody as compared to the nanoparticles alone (GNP.OH/COOH) (P<0.05) (Figure 7 E) . Different letters indicate significant differences between groups (P<0.05). 
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Inhibition of the inflammatory response in human keratinocytes
As it has been reported that TLR-2 receptor expressed in HaCaT keratinocytes can be activated Incubation with GNP.OH diminished only slightly, the levels of the pro-inflammatory IL-8,
even at the highest concentrations tested, which is probably related to their low enzymatic inhibitory activity. In contrast, GNP.OH/COOH, GNP.AEBSF, and GNP.antiKLK5
importantly decreased IL-8 levels down to 20%, even at very low concentrations. Significant differences were observed between particles at 100 µM, except for GNP.AEBSF and GNP.antiKLK5, which showed equivalent IL-8 levels. A completely different behavior was 
Inhibition of intracellular KLK5 in human keratinocytes
The potential of the functionalized nanoparticles to inhibit KLK5 activity ex vivo was evaluated under simulated Rosacea conditions. Hence, we measured the intracellular KLK5 activity in non- 
Conclusions
Water soluble monodisperse gold nanoparticles were synthesized, comprised of a gold core (ca.
1.5 nm diameter) and coated with a mixture of thiolated-PEG linkers of sufficient length that particles with hydrodynamic diameters around 10 nm (GNP.OH/COOH) are obtained, which were functionalized using the carboxyl terminal group on their surface. To explore the application of these GNP as delivery vehicles for drugs targeting key proteins altered in Rosacea, we immobilized the serine protease inhibitor AEBSF·HCl (either covalently or electrostatically) or the anti-KLK5 antibody (covalently). After functionalization, particles remain highly-water soluble giving no signs of aggregation as observed by TEM and DLS.
GNP (100 µM active groups)
In vitro KLK5 activity inhibition (%) 100% at all the concentrations tested, but a decrease in cell viability was observed with mixed hydroxyl/carboxyl functionalized gold nanoparticles (GNP.OH/COOH), an effect that may be attributed to the reactivity of free COOH groups on the surface of these nanoparticles. However, the most remarkable observation is that although the drug AEBSF·HCl in solution is highly cytotoxic, its incorporation to the nanoparticles through electrostatic, but especially through covalent bonding, significantly reduces its cytotoxicity, showing the high potential of the GNP to be used as drug delivery systems for highly cytotoxic drugs, as the complexation can increase drug safety. In the case of GNP.antiKLK5, the modest levels of toxicity observed are most probably related to the unreacted COOH groups remaining on the GNP surface. On this basis, we may speculate that a future chemical modification of these particles could lead to an increase in their safety, if after antibody attachment to the nanoparticles, the remaining COOH groups are blocked with other molecules, with the aim to create a non-toxic GNP surface, yet maintaining their high water solubility.
Drug-and antibody-functionalized particles, but remarkably, also GNP.OH/COOH particles without any further functionalization, inhibited in vitro KLK5 activity, in a similar way as the serine protease inhibitor AEBSF·HCl in solution.
Confocal fluorescence microscopy showed that BODIPY-labeled GNP.OH/COOH particles can be successfully internalized in HaCaT keratinocytes, and therefore the impairment of were purchased from Sartorius (Germany). Millex-GP syringe filters (polyether sulphone, 0.22 µm pore size) were purchased from Merck Millipore (Germany).
Methods
Synthesis and functionalization of gold nanoparticles
GNP were detected in aqueous solution by the observation of a red-violet color and the presence of a characteristic SPR band near λ=515 nm using a UV-1800 Shimadzu UV spectrophotometer (See Supporting Information, Figure S 1 ).
Size and concentration of gold nanoparticles
The extinction coefficient, concentration and size of GNP were estimated using UV-VIS absorption spectroscopy according to previously reported protocols. 22 As the thiolated-PEG molecules are the stabilizing agents of the GNP, their complete bond to them was assumed.
Therefore, the proportion of PEG.COOH to PEG.OH molecules in GNP.OH/COOH and in subsequent functionalizations was assumed to be 1: 1 the Analysis software (ImageJ®) using the particle-count tool.
LDI-TOF Mass spectrometry
Laser desorption/ionization time-of-flight mass spectrometry (LDI-TOF-MS) analysis was 
Thermogravimetric analysis (TGA)
Thermogravimetric analyses were performed on a Mettler-Toledo TGA-851e thermobalance at the CCiTUB. Experimental conditions: alumina crucibles of 70 µL volume, atmosphere of dry nitrogen with 50 mL/min flow rate, heating from 30 ºC to 1000 ºC with a heating rate of 10 ºC/min.
A blank curve has been previously performed and it has been subtracted.
Dynamic light scattering (DLS)
The average hydrodynamic diameter of GNP was determined through dynamic light scattering (DLS), using a Zetasizer Nano ZS, Malvern Instruments, Malvern, UK. The different GNP were diluted at different concentrations using 2 mM PBS, and all samples were filtered using 2 µm pore size syringe filters. At least three independent samples of each kind of nanoparticles were analyzed, performing 32 measurements in each analysis.
In vitro enzymatic inhibition of KLK5
Different functionalized and control GNP, previously washed with and resuspended in assay Mathematical models describing the inhibition were obtained and statistical analyses were performed using Prism GraphPad software.
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Cell line and growth conditions
The human keratinocyte (HaCaT) cell line (ATCC) was routinely grown in high-glucose Dubelcco's Modified Eagle's medium (DMEM) supplemented with 25 mM hepes, 1% nonessential amino acids, 100U/mL penicillin, 100 μg/mL streptomycin, and 10% heat inactivated fetal calf serum (FCS). Cells were cultured in a humidified incubator at 37⁰C in a 5% CO2
atmosphere and received fresh medium every 3 days. Experiments were performed at 80-90% of confluence (passes between n=85-95).
Internalization of GNPs in human keratinocytes
HaCaT (2x10 5 cells/mL) were seeded in 12-wells plates and grown 80-90% of confluence. Images were taken with a Nikon colour camera (16 bit) . The fluorescent excitation wavelengths were set to 485 nm (red; BODIPY) and 543 nm (green; membrane). Z-stacks were performed with a layer interval of 0.5 µm. Images were analysed using Fiji image software.
GNP.OH/COOH
MTT assay
The effect of the different GNPs on cell viability was evaluated using the MTT cytotoxicity For the inhibition of intracellular KLK5, enzymatic activity values after incubation of cells with GNP at a concentration of 100 µM of active groups were compared. Differences between more than two groups were assessed using one-way ANOVA followed by Tukey's test. Significant differences were always established at P ≤ 0.05. (Table S 1) , inhibition parameters from in-vitro KLK5 inhibition (Table   S 2 and Table S 3), statistical analyses from in-vitro KLK5 inhibition (Table S 4 ), cytotoxicity studies (Table S 5 ), anti-inflammatory activity of GNP (Table S 6 ), and inhibition of intracellular KLK5 activity (Table S 7 The following files are available free of charge. Supporting Information (PDF). 
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